XML 282 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class B common stock
Common stock
Common stock
Class B common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018       766,881,000          
Beginning balance at Dec. 31, 2018 $ 4,224,805     $ 7,669   $ 5,969,347 $ (1,680,432)   $ (71,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (424,150)           (424,150)    
Total other comprehensive income (loss), net of tax 13,403               13,403
Repurchases of common stock (in shares)       (23,883,000)          
Repurchases of common stock (149,868)     $ (239)   (149,629)      
Dividends, including dividends reinvested in common stock (in shares)       10,744,000          
Dividends, including dividends reinvested in common stock 565,456     $ 107   67,660 633,223    
Share-based compensation expense 85,626         85,626      
Transactions related to employee share-based compensation plans and other (in shares)       (120,000)          
Transactions related to employee share-based compensation plans and other 9     $ (1)   4,398 (4,388)    
Ending balance (in shares) at Dec. 31, 2019       753,622,000          
Ending balance at Dec. 31, 2019 3,184,369 $ (2,341)   $ 7,536   5,977,402 (2,742,193) $ (2,341) (58,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (632,193)           (632,193)    
Total other comprehensive income (loss), net of tax (60,239)               (60,239)
Issuance of common stock, net of expenses (in shares)       16,279,000 54,745,000        
Issuance of common stock, net of expenses 561,581     $ 163 $ 547 560,871      
Repurchases of common stock (in shares)       (1,000)          
Repurchases of common stock (4)         (4)      
Dividends, including dividends reinvested in common stock (in shares)       2,000          
Dividends, including dividends reinvested in common stock 111,853         15 111,868    
Share-based compensation expense 96,013         96,013      
Transactions related to employee share-based compensation plans and other (in shares)       1,112,000          
Transactions related to employee share-based compensation plans and other 4,003     $ 11   6,466 (2,474)    
Ending balance (in shares) at Dec. 31, 2020     54,744,525 771,014,000 54,745,000        
Ending balance at Dec. 31, 2020 3,039,336     $ 7,710 $ 547 6,640,763 (3,491,069)   (118,615)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (340,820)           (340,820)    
Total other comprehensive income (loss), net of tax 49,642               49,642
Issuance of common stock, net of expenses (in shares)       69,667,000          
Issuance of common stock, net of expenses 568,609     $ 697   567,912      
Dividends, including dividends reinvested in common stock 119,150         4 119,154    
Share-based compensation expense 61,237         61,237      
Transactions related to employee share-based compensation plans and other (in shares)       6,145,000          
Transactions related to employee share-based compensation plans and other 10,135     $ 61   (8,649) 1,547    
Ending balance (in shares) at Dec. 31, 2021     54,744,525 846,826,000 54,745,000        
Ending balance at Dec. 31, 2021 $ 3,248,719     $ 8,468 $ 547 $ 7,261,267 $ (3,952,590)   $ (68,973)